Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.

View in: PubMed

subject areas

Aged
Cerebral Hemorrhage
Female
Humans
Intention to Treat Analysis
Male
Middle Aged
Minimally Invasive Surgical Procedures
Thrombolytic Therapy
Treatment Outcome

authors with profiles

Issam Awad